spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  malapposition 

 HSMN NewsFeed - 8 Feb 2016
STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication
Devices Interventional Product Launch
 HSMN NewsFeed - 20 May 2014
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Jan 2014
STENTYS Expands Marketing of its Stents in Asia
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jul 2013
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Oct 2012
STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing(R) Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Oct 2012
STENTYS Self-Apposing(R) Stent Continues to Demonstrate Low Mortality at One Year in APPOSITION III Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
STENTYS Self-Apposing(R) Stent shows very low mortality at one month in 1,000 high-risk heart attack patients
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2012
STENTYS Expands Its Product Offerings for Treating Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2011
STENTYS Completes Enrollment of APPOSITION III Study for its Self-Apposing Stent to Treat Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 17 May 2011
Cappella Medical to Share Data Documenting Benefits of Full Ostial Protection at EuroPCR 2011
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Mar 2011
STENTYS Expands Operations into Four Additional European Countries
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 9 Dec 2010
STENTYS begins large-scale, "real life" study with its self-apposing stent for treatment of Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Dec 2010
Arterial Remodeling Technologies (“ART”) Discloses New Data for Its Breakthrough Bioresorbable Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Stentys Self-Apposing Stent Proves Superior to Conventional Treatment of Acute Myocardial Infarction
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jul 2010
Stentys completes enrollment in clinical study of its breakthrough stent to treat Acute Myocardial Infarction
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Mar 2010
Stentys self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 4 Dec 2009
First patient enrolled in randomized study of Stentys self-expanding stent vs. conventional stent to treat acute myocardial infarction (AMI)
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
Stentys Discloses Results for World's First Clinical Study to Treat Acute Myocardial Infarction (AMI) with a Self-Expanding Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Jul 2009
Stentys receives CE Mark approval
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 May 2009
Stentys Establishes U.S. Operations in Princeton, N.J.
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2009
Acute myocardial infarction (AMI) successfully treated with Stentys self-expanding platform, solving stent-malapposition
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Dec 2007
Volcano Announces Agreement to Acquire CardioSpectra
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 18 May 2007
Medtronic Announces Schedule of Activities at EuroPCR
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
malapposition
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.